EcoDrugPlus

Mast Cell Protease 1a-Like

Ensembl ID : ENSECRG00000017968
Gene Symbol: LOC114662708
2 Cross references
986 Possible Orthologues:

Mast Cell Protease 1a-Like

Ensembl ID : ENSECRG00000018029
Gene Symbol: LOC114662710
2 Cross references
986 Possible Orthologues:

Mast Cell Protease 1a-Like

Ensembl ID : ENSECRG00000019656
Gene Symbol: LOC114662716
2 Cross references
986 Possible Orthologues:

Mast Cell Protease 1a-Like

Ensembl ID : ENSECRG00000017754
Gene Symbol: LOC114662704
2 Cross references
986 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSECRG00000003942
Gene Symbol: MMP1
3 Cross references
323 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSECRG00000003949
Gene Symbol: MMP1
3 Cross references
323 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSECRG00000006675
Gene Symbol: MMP1
1 Cross references
142 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSECRG00000006660
Gene Symbol: MMP1
3 Cross references
142 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSECRG00000004986
Gene Symbol: MMP1
3 Cross references
323 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSECRG00000004020
Gene Symbol: MMP1
3 Cross references
323 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSECRG00000006653
Gene Symbol: MMP1
3 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSECRG00000004914
Gene Symbol: MMP14
3 Cross references
272 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).